We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Indivior Notes Former CEO's US DoJ Plea In "Personal Capacity"

Wed, 01st Jul 2020 10:50

(Alliance News) - Indivior PLC on Wednesday noted that former chief executive Shaun Thaxter has entered into a plea agreement with the US Department of Justice.

He has pleaded guilty to one misdemeanor count under the Responsible Corporate Officer Doctrine.

The plea agreement between Thaxter and the DoJ is "in his personal capacity and not on behalf of the group", Indivior stressed.

"As the group has previously noted, it continues to pursue its strategy to resolve outstanding investigations and litigations as expeditiously as possible, and as the matter is ongoing it has no further comment," the drug maker said.

On Monday, Indivior said Chief Financial & Operations Officer Mark Crossley would replace Thaxter as chief executive with immediate effect. Thaxter, in mutual agreement with the board, stepped down as chief executive and executive director.

Indivior is currently locked in a legal battle over Suboxone Film, after it was indicted by a grand jury in a case bought by the US Department of Justice. The DoJ is seeking USD3 billion and has accused Indivior of health care fraud, wire fraud, mail fraud, and conspiracy in connection with its marketing and promotion of Suboxone Film, as well as paediatric safety claims and over-prescription.

Indivior shares were up 1.3% at 84.09 pence in London on Wednesday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its lis...

25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net ...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 eac...

12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.